The global OTC Dry Eye Drops market is projected to grow from US$ 2587 million in 2024 to US$ 3280 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

OTC Dry Eye Drops Market

This report studies OTC dry eyedrop market. OTC eyedrops refer to eyedrops dispensed without a prescription. Over-the-counter eye drops offer a convenient assortment for various eye health needs.

From a downstream perspective, Teenagers accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

OTC Dry Eye Drops leading manufacturers including Alcon, Bausch Health, AbbVie, Santen Pharma, CooperVision, Thea pharmaceuticals, URSAPHARM, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, etc., dominate supply; the top five capture approximately % of global revenue, with Alcon leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global OTC Dry Eye Drops market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of OTC Dry Eye Drops Market Report

Report Metric	Details
Report Name	OTC Dry Eye Drops Market
Accounted market size in 2024	US$ 2587 million
Forecasted market size in 2031	US$ 3280 million
CAGR	3.5%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Sodium Hyaluronate Eye Drops Sodium Carboxymethylcellulose Eye Drops Other
Segment by Application	Teenagers Middle Age Older Adult
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alcon, Bausch Health, AbbVie, Santen Pharma, CooperVision, Thea pharmaceuticals, URSAPHARM, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE), Zhenshiming
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the OTC Dry Eye Drops study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is OTC Dry Eye Drops Market growing?

Ans: The OTC Dry Eye Drops Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the OTC Dry Eye Drops Market size in 2031?

Ans: The OTC Dry Eye Drops Market size in 2031 will be US$ 3280 million.

Who are the main players in the OTC Dry Eye Drops Market report?

Ans: The main players in the OTC Dry Eye Drops Market are Alcon, Bausch Health, AbbVie, Santen Pharma, CooperVision, Thea pharmaceuticals, URSAPHARM, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE), Zhenshiming

What are the Application segmentation covered in the OTC Dry Eye Drops Market report?

Ans: The Applications covered in the OTC Dry Eye Drops Market report are Teenagers, Middle Age, Older Adult

What are the Type segmentation covered in the OTC Dry Eye Drops Market report?

Ans: The Types covered in the OTC Dry Eye Drops Market report are Sodium Hyaluronate Eye Drops, Sodium Carboxymethylcellulose Eye Drops, Other

1 Study Coverage

1.1 Introduction to OTC Dry Eye Drops: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global OTC Dry Eye Drops Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Sodium Hyaluronate Eye Drops

1.2.3 Sodium Carboxymethylcellulose Eye Drops

1.2.4 Other

1.3 Market Segmentation by Application

1.3.1 Global OTC Dry Eye Drops Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Teenagers

1.3.3 Middle Age

1.3.4 Older Adult

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global OTC Dry Eye Drops Revenue Estimates and Forecasts 2020-2031

2.2 Global OTC Dry Eye Drops Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global OTC Dry Eye Drops Sales Estimates and Forecasts 2020-2031

2.4 Global OTC Dry Eye Drops Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global OTC Dry Eye Drops Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global OTC Dry Eye Drops Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Sodium Hyaluronate Eye Drops Market Size by Manufacturers

3.5.2 Sodium Carboxymethylcellulose Eye Drops Market Size by Manufacturers

3.5.3 Other Market Size by Manufacturers

3.6 Global OTC Dry Eye Drops Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global OTC Dry Eye Drops Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global OTC Dry Eye Drops Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global OTC Dry Eye Drops Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global OTC Dry Eye Drops Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America OTC Dry Eye Drops Sales and Revenue by Type (2020-2031)

6.4 North America OTC Dry Eye Drops Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America OTC Dry Eye Drops Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe OTC Dry Eye Drops Sales and Revenue by Type (2020-2031)

7.4 Europe OTC Dry Eye Drops Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe OTC Dry Eye Drops Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific OTC Dry Eye Drops Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific OTC Dry Eye Drops Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific OTC Dry Eye Drops Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America OTC Dry Eye Drops Sales and Revenue by Type (2020-2031)

9.4 Central and South America OTC Dry Eye Drops Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America OTC Dry Eye Drops Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa OTC Dry Eye Drops Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa OTC Dry Eye Drops Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa OTC Dry Eye Drops Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Alcon

11.1.1 Alcon Corporation Information

11.1.2 Alcon Business Overview

11.1.3 Alcon OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.1.4 Alcon OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Alcon OTC Dry Eye Drops Sales by Product in 2024

11.1.6 Alcon OTC Dry Eye Drops Sales by Application in 2024

11.1.7 Alcon OTC Dry Eye Drops Sales by Geographic Area in 2024

11.1.8 Alcon OTC Dry Eye Drops SWOT Analysis

11.1.9 Alcon Recent Developments

11.2 Bausch Health

11.2.1 Bausch Health Corporation Information

11.2.2 Bausch Health Business Overview

11.2.3 Bausch Health OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.2.4 Bausch Health OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Bausch Health OTC Dry Eye Drops Sales by Product in 2024

11.2.6 Bausch Health OTC Dry Eye Drops Sales by Application in 2024

11.2.7 Bausch Health OTC Dry Eye Drops Sales by Geographic Area in 2024

11.2.8 Bausch Health OTC Dry Eye Drops SWOT Analysis

11.2.9 Bausch Health Recent Developments

11.3 AbbVie

11.3.1 AbbVie Corporation Information

11.3.2 AbbVie Business Overview

11.3.3 AbbVie OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.3.4 AbbVie OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 AbbVie OTC Dry Eye Drops Sales by Product in 2024

11.3.6 AbbVie OTC Dry Eye Drops Sales by Application in 2024

11.3.7 AbbVie OTC Dry Eye Drops Sales by Geographic Area in 2024

11.3.8 AbbVie OTC Dry Eye Drops SWOT Analysis

11.3.9 AbbVie Recent Developments

11.4 Santen Pharma

11.4.1 Santen Pharma Corporation Information

11.4.2 Santen Pharma Business Overview

11.4.3 Santen Pharma OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.4.4 Santen Pharma OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Santen Pharma OTC Dry Eye Drops Sales by Product in 2024

11.4.6 Santen Pharma OTC Dry Eye Drops Sales by Application in 2024

11.4.7 Santen Pharma OTC Dry Eye Drops Sales by Geographic Area in 2024

11.4.8 Santen Pharma OTC Dry Eye Drops SWOT Analysis

11.4.9 Santen Pharma Recent Developments

11.5 CooperVision

11.5.1 CooperVision Corporation Information

11.5.2 CooperVision Business Overview

11.5.3 CooperVision OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.5.4 CooperVision OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 CooperVision OTC Dry Eye Drops Sales by Product in 2024

11.5.6 CooperVision OTC Dry Eye Drops Sales by Application in 2024

11.5.7 CooperVision OTC Dry Eye Drops Sales by Geographic Area in 2024

11.5.8 CooperVision OTC Dry Eye Drops SWOT Analysis

11.5.9 CooperVision Recent Developments

11.6 Thea pharmaceuticals

11.6.1 Thea pharmaceuticals Corporation Information

11.6.2 Thea pharmaceuticals Business Overview

11.6.3 Thea pharmaceuticals OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.6.4 Thea pharmaceuticals OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Thea pharmaceuticals Recent Developments

11.7 URSAPHARM

11.7.1 URSAPHARM Corporation Information

11.7.2 URSAPHARM Business Overview

11.7.3 URSAPHARM OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.7.4 URSAPHARM OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 URSAPHARM Recent Developments

11.8 OmniVision Pharma

11.8.1 OmniVision Pharma Corporation Information

11.8.2 OmniVision Pharma Business Overview

11.8.3 OmniVision Pharma OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.8.4 OmniVision Pharma OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 OmniVision Pharma Recent Developments

11.9 Rohto

11.9.1 Rohto Corporation Information

11.9.2 Rohto Business Overview

11.9.3 Rohto OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.9.4 Rohto OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Rohto Recent Developments

11.10 Prestige Consumer Healthcare

11.10.1 Prestige Consumer Healthcare Corporation Information

11.10.2 Prestige Consumer Healthcare Business Overview

11.10.3 Prestige Consumer Healthcare OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.10.4 Prestige Consumer Healthcare OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Prestige Consumer Healthcare Recent Developments

11.11 LION

11.11.1 LION Corporation Information

11.11.2 LION Business Overview

11.11.3 LION OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.11.4 LION OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 LION Recent Developments

11.12 Kenvue (VISINE)

11.12.1 Kenvue (VISINE) Corporation Information

11.12.2 Kenvue (VISINE) Business Overview

11.12.3 Kenvue (VISINE) OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.12.4 Kenvue (VISINE) OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Kenvue (VISINE) Recent Developments

11.13 Zhenshiming

11.13.1 Zhenshiming Corporation Information

11.13.2 Zhenshiming Business Overview

11.13.3 Zhenshiming OTC Dry Eye Drops Product Models, Descriptions and Specifications

11.13.4 Zhenshiming OTC Dry Eye Drops Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 Zhenshiming Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 OTC Dry Eye Drops Industry Chain

12.2 OTC Dry Eye Drops Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 OTC Dry Eye Drops Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 OTC Dry Eye Drops Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 OTC Dry Eye Drops Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global OTC Dry Eye Drops Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Prestige Consumer Healthcare

Lion

Kenvue (VISINE)

Zhenshiming

List of Tables

Table 1. Global OTC Dry Eye Drops Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global OTC Dry Eye Drops Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global OTC Dry Eye Drops Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global OTC Dry Eye Drops Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global OTC Dry Eye Drops Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global OTC Dry Eye Drops Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global OTC Dry Eye Drops Sales by Region (2020-2025) & (K Units)

Table 8. Global OTC Dry Eye Drops Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global OTC Dry Eye Drops Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global OTC Dry Eye Drops Sales Share by Manufacturers (2020-2025)

Table 12. Global OTC Dry Eye Drops Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global OTC Dry Eye Drops Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global OTC Dry Eye Drops by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Dry Eye Drops as of 2024)

Table 16. Global OTC Dry Eye Drops Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global OTC Dry Eye Drops Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers OTC Dry Eye Drops Manufacturing Base and Headquarters

Table 19. Global OTC Dry Eye Drops Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global OTC Dry Eye Drops Sales by Type (2020-2025) & (K Units)

Table 23. Global OTC Dry Eye Drops Sales by Type (2026-2031) & (K Units)

Table 24. Global OTC Dry Eye Drops Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global OTC Dry Eye Drops Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global OTC Dry Eye Drops ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global OTC Dry Eye Drops Sales by Application (2020-2025) & (K Units)

Table 29. Global OTC Dry Eye Drops Sales by Application (2026-2031) & (K Units)

Table 30. OTC Dry Eye Drops High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global OTC Dry Eye Drops Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global OTC Dry Eye Drops Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global OTC Dry Eye Drops ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America OTC Dry Eye Drops Growth Accelerators and Market Barriers

Table 37. North America OTC Dry Eye Drops Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America OTC Dry Eye Drops Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe OTC Dry Eye Drops Growth Accelerators and Market Barriers

Table 40. Europe OTC Dry Eye Drops Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe OTC Dry Eye Drops Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific OTC Dry Eye Drops Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific OTC Dry Eye Drops Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific OTC Dry Eye Drops Growth Accelerators and Market Barriers

Table 45. Southeast Asia OTC Dry Eye Drops Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America OTC Dry Eye Drops Investment Opportunities and Key Challenges

Table 47. Central and South America OTC Dry Eye Drops Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa OTC Dry Eye Drops Investment Opportunities and Key Challenges

Table 49. Middle East and Africa OTC Dry Eye Drops Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Alcon Corporation Information

Table 51. Alcon Description and Major Businesses

Table 52. Alcon Product Models, Descriptions and Specifications

Table 53. Alcon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Alcon Sales Value Proportion by Product in 2024

Table 55. Alcon Sales Value Proportion by Application in 2024

Table 56. Alcon Sales Value Proportion by Geographic Area in 2024

Table 57. Alcon OTC Dry Eye Drops SWOT Analysis

Table 58. Alcon Recent Developments

Table 59. Bausch Health Corporation Information

Table 60. Bausch Health Description and Major Businesses

Table 61. Bausch Health Product Models, Descriptions and Specifications

Table 62. Bausch Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Bausch Health Sales Value Proportion by Product in 2024

Table 64. Bausch Health Sales Value Proportion by Application in 2024

Table 65. Bausch Health Sales Value Proportion by Geographic Area in 2024

Table 66. Bausch Health OTC Dry Eye Drops SWOT Analysis

Table 67. Bausch Health Recent Developments

Table 68. AbbVie Corporation Information

Table 69. AbbVie Description and Major Businesses

Table 70. AbbVie Product Models, Descriptions and Specifications

Table 71. AbbVie Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. AbbVie Sales Value Proportion by Product in 2024

Table 73. AbbVie Sales Value Proportion by Application in 2024

Table 74. AbbVie Sales Value Proportion by Geographic Area in 2024

Table 75. AbbVie OTC Dry Eye Drops SWOT Analysis

Table 76. AbbVie Recent Developments

Table 77. Santen Pharma Corporation Information

Table 78. Santen Pharma Description and Major Businesses

Table 79. Santen Pharma Product Models, Descriptions and Specifications

Table 80. Santen Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Santen Pharma Sales Value Proportion by Product in 2024

Table 82. Santen Pharma Sales Value Proportion by Application in 2024

Table 83. Santen Pharma Sales Value Proportion by Geographic Area in 2024

Table 84. Santen Pharma OTC Dry Eye Drops SWOT Analysis

Table 85. Santen Pharma Recent Developments

Table 86. CooperVision Corporation Information

Table 87. CooperVision Description and Major Businesses

Table 88. CooperVision Product Models, Descriptions and Specifications

Table 89. CooperVision Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. CooperVision Sales Value Proportion by Product in 2024

Table 91. CooperVision Sales Value Proportion by Application in 2024

Table 92. CooperVision Sales Value Proportion by Geographic Area in 2024

Table 93. CooperVision OTC Dry Eye Drops SWOT Analysis

Table 94. CooperVision Recent Developments

Table 95. Thea pharmaceuticals Corporation Information

Table 96. Thea pharmaceuticals Description and Major Businesses

Table 97. Thea pharmaceuticals Product Models, Descriptions and Specifications

Table 98. Thea pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Thea pharmaceuticals Recent Developments

Table 100. URSAPHARM Corporation Information

Table 101. URSAPHARM Description and Major Businesses

Table 102. URSAPHARM Product Models, Descriptions and Specifications

Table 103. URSAPHARM Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. URSAPHARM Recent Developments

Table 105. OmniVision Pharma Corporation Information

Table 106. OmniVision Pharma Description and Major Businesses

Table 107. OmniVision Pharma Product Models, Descriptions and Specifications

Table 108. OmniVision Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. OmniVision Pharma Recent Developments

Table 110. Rohto Corporation Information

Table 111. Rohto Description and Major Businesses

Table 112. Rohto Product Models, Descriptions and Specifications

Table 113. Rohto Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Rohto Recent Developments

Table 115. Prestige Consumer Healthcare Corporation Information

Table 116. Prestige Consumer Healthcare Description and Major Businesses

Table 117. Prestige Consumer Healthcare Product Models, Descriptions and Specifications

Table 118. Prestige Consumer Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Prestige Consumer Healthcare Recent Developments

Table 120. LION Corporation Information

Table 121. LION Description and Major Businesses

Table 122. LION Product Models, Descriptions and Specifications

Table 123. LION Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. LION Recent Developments

Table 125. Kenvue (VISINE) Corporation Information

Table 126. Kenvue (VISINE) Description and Major Businesses

Table 127. Kenvue (VISINE) Product Models, Descriptions and Specifications

Table 128. Kenvue (VISINE) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Kenvue (VISINE) Recent Developments

Table 130. Zhenshiming Corporation Information

Table 131. Zhenshiming Description and Major Businesses

Table 132. Zhenshiming Product Models, Descriptions and Specifications

Table 133. Zhenshiming Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. Zhenshiming Recent Developments

Table 135. Key Raw Materials Distribution

Table 136. Raw Materials Key Suppliers

Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 138. Milestones in Production Technology Evolution

Table 139. Distributors List

Table 140. Market Trends and Market Evolution

Table 141. Market Drivers and Opportunities

Table 142. Market Challenges, Risks, and Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. OTC Dry Eye Drops Product Picture

Figure 2. Global OTC Dry Eye Drops Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Sodium Hyaluronate Eye Drops Product Picture

Figure 4. Sodium Carboxymethylcellulose Eye Drops Product Picture

Figure 5. Other Product Picture

Figure 6. Global OTC Dry Eye Drops Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Teenagers

Figure 8. Middle Age

Figure 9. Older Adult

Figure 10. OTC Dry Eye Drops Report Years Considered

Figure 11. Global OTC Dry Eye Drops Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 13. Global OTC Dry Eye Drops Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global OTC Dry Eye Drops Revenue Market Share by Region (2020-2031)

Figure 15. Global OTC Dry Eye Drops Sales (2020-2031) & (K Units)

Figure 16. Global OTC Dry Eye Drops Sales (CAGR) by Region (2020-2031) (K Units)

Figure 17. Global OTC Dry Eye Drops Sales Market Share by Region (2020-2031)

Figure 18. Top 5 and Top 10 Manufacturers OTC Dry Eye Drops Sales Volume Market Share in 2024

Figure 19. Global OTC Dry Eye Drops Revenue Market Share Ranking (2024)

Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 21. Sodium Hyaluronate Eye Drops Revenue Market Share by Manufacturer in 2024

Figure 22. Sodium Carboxymethylcellulose Eye Drops Revenue Market Share by Manufacturer in 2024

Figure 23. Other Revenue Market Share by Manufacturer in 2024

Figure 24. Global OTC Dry Eye Drops Sales Market Share by Type (2020-2031)

Figure 25. Global OTC Dry Eye Drops Revenue Market Share by Type (2020-2031)

Figure 26. Global OTC Dry Eye Drops Sales Market Share by Application (2020-2031)

Figure 27. Global OTC Dry Eye Drops Revenue Market Share by Application (2020-2031)

Figure 28. North America OTC Dry Eye Drops Sales YoY (2020-2031) & (K Units)

Figure 29. North America OTC Dry Eye Drops Revenue YoY (2020-2031) & (US$ Million)

Figure 30. North America Top 5 Manufacturers OTC Dry Eye Drops Sales Revenue (US$ Million) in 2024

Figure 31. North America OTC Dry Eye Drops Sales Volume (K Units) by Type (2020- 2031)

Figure 32. North America OTC Dry Eye Drops Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 33. North America OTC Dry Eye Drops Sales Volume (K Units) by Application (2020-2031)

Figure 34. North America OTC Dry Eye Drops Sales Revenue (US$ Million) by Application (2020-2031)

Figure 35. US OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 36. Canada OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 37. Mexico OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 38. Europe OTC Dry Eye Drops Sales YoY (2020-2031) & (K Units)

Figure 39. Europe OTC Dry Eye Drops Revenue YoY (2020-2031) & (US$ Million)

Figure 40. Europe Top 5 Manufacturers OTC Dry Eye Drops Sales Revenue (US$ Million) in 2024

Figure 41. Europe OTC Dry Eye Drops Sales Volume (K Units) by Type (2020-2031)

Figure 42. Europe OTC Dry Eye Drops Sales Revenue (US$ Million) by Type (2020-2031)

Figure 43. Europe OTC Dry Eye Drops Sales Volume (K Units) by Application (2020-2031)

Figure 44. Europe OTC Dry Eye Drops Sales Revenue (US$ Million) by Application (2020-2031)

Figure 45. Germany OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 46. France OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 47. U.K. OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 48. Italy OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 49. Russia OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific OTC Dry Eye Drops Sales YoY (2020-2031) & (K Units)

Figure 51. Asia-Pacific OTC Dry Eye Drops Revenue YoY (2020-2031) & (US$ Million)

Figure 52. Asia-Pacific Top 8 Manufacturers OTC Dry Eye Drops Sales Revenue (US$ Million) in 2024

Figure 53. Asia-Pacific OTC Dry Eye Drops Sales Volume (K Units) by Type (2020- 2031)

Figure 54. Asia-Pacific OTC Dry Eye Drops Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 55. Asia-Pacific OTC Dry Eye Drops Sales Volume (K Units) by Application (2020-2031)

Figure 56. Asia-Pacific OTC Dry Eye Drops Sales Revenue (US$ Million) by Application (2020-2031)

Figure 57. Indonesia OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 58. Japan OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 59. South Korea OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 60. China Taiwan OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 61. India OTC Dry Eye Drops Revenue (2020-2031) & (US$ Million)

Figure 62. Central and South America OTC Dry Eye Drops Sales YoY (2020-2031) & (K Units)

Figure 63. Central and South America OTC Dry Eye Drops Revenue YoY (2020-2031) & (US$ Million)

Figure 64. Central and South America Top 5 Manufacturers OTC Dry Eye Drops Sales Revenue (US$ Million) in 2024

Figure 65. Central and South America OTC Dry Eye Drops Sales Volume (K Units) by Type (2021-2031)

Figure 66. Central and South America OTC Dry Eye Drops Sales Revenue (US$ Million) by Type (2020-2031)

Figure 67. Central and South America OTC Dry Eye Drops Sales Volume (K Units) by Application (2020-2031)

Figure 68. Central and South America OTC Dry Eye Drops Sales Revenue (US$ Million) by Application (2020-2031)

Figure 69. Brazil OTC Dry Eye Drops Revenue (2020-2025) & (US$ Million)

Figure 70. Argentina OTC Dry Eye Drops Revenue (2020-2025) & (US$ Million)

Figure 71. Middle East, and Africa OTC Dry Eye Drops Sales YoY (2020-2031) & (K Units)

Figure 72. Middle East and Africa OTC Dry Eye Drops Revenue YoY (2020-2031) & (US$ Million)

Figure 73. Middle East and Africa Top 5 Manufacturers OTC Dry Eye Drops Sales Revenue (US$ Million) in 2024

Figure 74. Middle East and Africa OTC Dry Eye Drops Sales Volume (K Units) by Type (2021-2031)

Figure 75. South America OTC Dry Eye Drops Sales Revenue (US$ Million) by Type (2020-2031)

Figure 76. Middle East and Africa OTC Dry Eye Drops Sales Volume (K Units) by Application (2020-2031)

Figure 77. Middle East and Africa OTC Dry Eye Drops Sales Revenue (US$ Million) by Application (2020-2031)

Figure 78. GCC Countries OTC Dry Eye Drops Revenue (2020-2025) & (US$ Million)

Figure 79. Turkey OTC Dry Eye Drops Revenue (2020-2025) & (US$ Million)

Figure 80. Egypt OTC Dry Eye Drops Revenue (2020-2025) & (US$ Million)

Figure 81. South Africa OTC Dry Eye Drops Revenue (2020-2025) & (US$ Million)

Figure 82. OTC Dry Eye Drops Industry Chain Mapping

Figure 83. Regional OTC Dry Eye Drops Manufacturing Base Distribution (%)

Figure 84. Global OTC Dry Eye Drops Production Market Share by Region (2020-2031)

Figure 85. OTC Dry Eye Drops Production Process

Figure 86. Regional OTC Dry Eye Drops Production Cost Structure

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions